The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrcadian Engy Regulatory News (ORCA)

Share Price Information for Orcadian Engy (ORCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.875
Bid: 10.50
Ask: 11.25
Change: 0.00 (0.00%)
Spread: 0.75 (7.143%)
Open: 10.875
High: 10.875
Low: 10.875
Prev. Close: 10.875
ORCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£350,000 equity financing & Update of 33rd Round

2 Oct 2023 07:00

RNS Number : 2652O
Orcadian Energy PLC
02 October 2023
 

 

 

 

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

02 October 2023

Orcadian Energy plc

("Orcadian Energy", "Orcadian" or the "Company")

 

 £350,000 equity financing

Update of 33rd Licencing Round

 

Orcadian is pleased to announce that it has today raised gross proceeds of £350,000 through the issue of 2,916,666 new ordinary shares of the Company (the "New Ordinary Shares") at a price per New Ordinary Share of £0.12. These funds are raised as part of a direct subscription with the Company with new investors.  The subscription price represents a discount of approximately 14% to the closing mid-price of an ordinary share in the Company on 29 September 2023, being the latest practicable day prior to the publication of this announcement.

The proceeds will be applied to ongoing working capital, the costs involved in the progressing the proposed farm-in agreements as announced on 18 September 2023 and the repayment of certain creditors. The Company will need to raise further funds in the near term to continue to progress its activities and further updates will be provided in due course.

 

Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM, and it is expected that dealings in the New Ordinary Shares will commence on or around 5 October 2023.  The New Ordinary Shares will be issued fully paid and will rank pari passu to the Company's existing ordinary shares.

 

Immediately following Admission, the Company's issued share capital will be 75,428,983 Ordinary Shares, with each share carrying the right to one vote. The Company does not hold any Ordinary Shares in treasury. The total voting rights figure immediately following Admission, of 75,428,983 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

  

Steve Brown, Orcadian's CEO, said:

 

"We are delighted to welcome our new investors on board. Though more funding was made available to the Company from other groups, we are continuing to minimise Company overheads whilst seeking to add value per share. As a Company we also remain very cognisant of keeping shareholder dilution to a minimum.  These funds will enable us to progress the proposed farm-in deal that we announced as well as helping us unlock the inherent value we have always believed is in the Company for our shareholders.

 

"We look forward to providing updates on the proposed farm-in to the Pilot Project and the outcome of our applications in the 33rd Offshore Licensing Round."

33rd Licencing Round

As announced on 19 January 2023, the Company made three licence applications, two in partnership with other companies and one on its own. One of the applications builds upon Orcadian's viscous oil experience whilst the other two applications are focused on gas opportunities, including a potential gas-to-wire project on an appraised discovery, with integrated carbon capture, which could deliver baseload electricity with minimal emissions. Early stage indications suggest that, net to Orcadian, the P50 sales gas resource applied for, across the two gas focused applications, could amount to 114 bcf (billion cubic feet) in a discovery, 153 bcf in a near drill-ready prospect and 377 bcf in leads and less mature prospects. However, these are management estimates of resources, are based upon seismic and well log data, are as presented to the NSTA in the Licence Applications, and are provided here for guidance purposes only.

The Company anticipates that it will hear as to whether its licence applications have been successful during fourth quarter 2023 and a further announcement will be made when NSTA publish the results of the round.

 

For further information on the Company please visit the Company's website: https://orcadian.energy

 

Contact:

 

Orcadian Energy plc

+ 44 20 7920 3150

Steve Brown, CEO

Alan Hume, CFO

WH Ireland (Nomad and Joint Broker)

+44 20 7220 1666

Katy Mitchell / Andrew de Andrade (Nomad)

Harry Ansell / Fraser Marshall (Corporate Broking)

 

Tavistock (PR)

+ 44 20 7920 3150

Nick Elwes / Simon Hudson

orcadian@tavistock.co.uk

 

 

About Orcadian Energy

Orcadian is a North Sea focused, low emissions, oil and gas development company. In planning its Pilot development, Orcadian has selected wind power to transform oil production into a cleaner and greener process. The Pilot project is moving towards approval and will be amongst the lowest carbon emitting oil production facilities in the world, despite being a viscous crude. Orcadian may be a small operator, but it is also nimble, and the Directors believe it has grasped opportunities that have eluded some of the much bigger companies. As we strike a balance between Net Zero and a sustainable energy supply, Orcadian intends to play its part to minimise the cost of Net Zero and to deliver reliable energy to the UK.

Orcadian Energy (CNS) Ltd, Orcadian's operating subsidiary, was founded in 2014 and is the sole licensee of P2244, which contains 78.0 MMbbl of 2P Reserves in the Pilot discovery, and of P2482, which contain a further 52.2 MMbbl of 2C Contingent Resources in the Elke and Narwhal discoveries (as audited by Sproule, with both numbers modified to take into account the TGS royalty, see the CPR in the Company's Admission Document for more details). Within these licences there are also 118 MMbbl of unrisked Prospective Resources (modified for TGS royalty). These licences are in blocks 21/27a, 28/2a and 28/3a, and lie 150 kms due East of Aberdeen. 

Pilot, which is the field with the largest reserves in Orcadian's portfolio, was discovered by PetroFina in 1989 and has been well appraised. In total five wells and two sidetracks were drilled on Pilot, including a relatively short horizontal well which produced over 1,800 bbls/day on test. Orcadian's proposed low emissions, field development plan for Pilot is based upon a Floating Production Storage and Offloading vessel (FPSO), with over thirty wells to be drilled by a Jack-up rig and provision of power from a floating wind turbine.

Orcadian has entered into a non-binding heads of terms with a North Sea Operator which details the terms under which the Operator could farm-in to the Pilot development project. If the proposed deal was to progress in accordance with its outline terms, Orcadian would have an 18.75% stake in the Pilot development with all pre-first oil development costs paid by the North Sea Operator.

Emissions per barrel produced are expected to be about a tenth of the 2021 North Sea average, and less than half of the lowest emitting oil facility currently operating on the UKCS. On a global basis this places the Pilot field emissions at the low end of the lowest 5% of global oil production.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMGGRMMGFZM
Date   Source Headline
8th Apr 20242:46 pmRNSHolding(s) in Company
8th Apr 20242:44 pmRNSHolding(s) in Company
4th Apr 202411:03 amRNSInvestor Presentation via Investor Meet Company
2nd Apr 20247:00 amRNSCompletion of Pilot Farm-out
18th Mar 20247:00 amRNSChange of Nominated Adviser and Broker
14th Mar 202411:04 amRNSAmendment to Facility Agreement
27th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
1st Feb 20247:00 amRNS33rd Licensing Round Offer of Awards
17th Jan 202412:45 pmRNSResult of General Meeting & Annual General Meeting
15th Jan 20242:56 pmRNSHolding(s) in Company
12th Jan 202410:57 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSCirc re. Disposal & Notice of GM
18th Dec 20237:15 amRNS£500,000 equity financing & TVR
18th Dec 20237:02 amRNS33rd Licensing Round Update
18th Dec 20237:00 amRNSFinal Results
8th Dec 20237:00 amRNSInvestor Presentation via Investor Meet Company
7th Dec 202311:12 amRNSPilot Farm-out Deal and Partnership with Ping
1st Dec 20237:00 amRNSPilot Farm-out Update
7th Nov 20237:28 amRNSAnnual Licensing Rounds
25th Oct 20237:00 amRNSTwo Year Pilot Licence Extension
23rd Oct 20237:00 amRNSLock-in agreement
2nd Oct 20237:00 amRNS£350,000 equity financing & Update of 33rd Round
21st Sep 202312:37 pmRNSPDMR Update
19th Sep 20237:00 amRNSInvestor Presentation via Investor Meet Company
18th Sep 20237:00 amRNSProposed Farm-in to the Pilot Project
13th Sep 20231:32 pmRNSAmendment to Facility Agreement
23rd Aug 20237:00 amRNSAmendment to Facility Agreement
2nd Aug 202312:06 pmRNSShare Price Movement Update
1st Aug 20237:00 amRNSHolding(s) in Company
15th May 20237:00 amRNSDetermination of Licence P2320
30th Mar 20237:00 amRNSResults for the half year ended 31 December 2022
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
2nd Feb 202311:05 amRNSSecond Price Monitoring Extn
2nd Feb 202311:00 amRNSPrice Monitoring Extension
2nd Feb 20239:05 amRNSSecond Price Monitoring Extn
2nd Feb 20239:00 amRNSPrice Monitoring Extension
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20232:05 pmRNSSecond Price Monitoring Extn
1st Feb 20232:00 pmRNSPrice Monitoring Extension
1st Feb 202311:05 amRNSSecond Price Monitoring Extn
1st Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 202310:01 amRNSResult of Placing
1st Feb 20237:00 amRNSProposed Placing to raise approximately £0.5m
19th Jan 20237:00 amRNS33rd Offshore Licensing Round
17th Jan 20231:05 pmRNSResult of Annual General Meeting
11th Jan 20237:00 amRNSProposed Disposal of Crinan and Dandy discoveries
10th Jan 20237:00 amRNSPilot Technical Resource Upgrade

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.